AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Abel Seifu Abegaz

Appears inactive Last observed office action: July 2025 (11 months ago).

Examiner Abel Seifu Abegaz appears to be very easy relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 57.6%, they average 1.50 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU Very Easy
Difficulty vs Group Very Easy
Difficulty vs TC Very Easy
Difficulty vs USPTO Very Easy
Average OA / Grant 1.50
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
3 years (2023-2025)
Tech Center
3700 - Mechanical Engineering, Manufacturing and Products
Group
3790 - Medical Instruments, Diagnostic Equipment, and Treatment Devices

Metrics

Applications Evaluated
59
Granted Applications
34
Non-Granted Applications
25
Avg OA / Grant
1.50
Last OA Observed
July 2025 (11 months ago)
Art Units Seen
3791
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 57.6% 1.50
Art Unit 102 35.9% 2.09
Group 327 40.3% 2.25
Tech Center 2,632 49.9% 2.01
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2023 2024 2025
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2023; examiner may not yet have been active in the available dataset.
2023 6 3 50.0%
2024 24 19 79.2%
2025 29 12 41.4%
No observed data after 2025; examiner may have gone inactive or moved out of examining work.

34 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 70 1.4% 4.3% 78.6% 15.7%
2 26 7.7% 26.9% 57.7% 7.7%
3 13 0.0% 15.4% 84.6% 0.0%
4 2 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
0.0%
2023
1.7%
2024
4.4%
2025

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.